CLINICAL_TRIALS
trial_result
· 2023-03-31
Clinical Trial Update: Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain [Phase 3]
Summary
Phase 3 trial evaluating magnesium-based trigger point injections for chronic myofascial pelvic pain; study terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Queen's University | Conditions: Pelvic Pain | Phase 3 | Status: TERMINATED